1. Transporters 2013. 11. 29. Lee,Sang-Hwi

2. 9.1 Transporter Fundamentals Physicochemical properties lipophilicity hydrogen bonds M.W. Toxic xenobiotics (drugs) ADME / Toxicity Passive Diffusion Paracellular Uptake Transport Transcytosis Efflux Transport

3. 9.2 Transporter Effects

4. 9.2.1 Transporters in Intestinal Epithelial Cells 1. Absorptive uptake (absorption : 약물 농도 증가 ) 2. Secretory efflux ( 약물 농도 감소 ) 3. efflux 혈관 Gastric lumen 위 장

5. 9.2.2 Transporters in Liver Hepatocytes biliary clearance (Excretion) Hepatic uptake (Excretion) Hepatocyte efflux (Retention recirculation) Frontiers in Bioscience 14, 2599, 2009 간 혈관 담모세관

6. 9.2.3 Transporters in Kidney Epithelial Cells Reabsorption Tubular secretion 혈관 신장 소변

7. 9.2.4 Transporters in Blood–Brain Barrier Endothelial Cells - efflux (from the BBB endothelial cells back into the blood) - uptake (from the blood, through the BBB endothelial cells and into the brain)

8. 9.3 Efflux Transporters  Efflux transporters facilitate the export of compounds from the cell.  These transporters belong to the ATP-binding cassette (ABC) family.

9. 9.3.1 P-glycoprotein (MDR1, ABCB1) [Efflux] NH2 COOH N-linked glycosylation site (N91, N94, N99) Phosphorylation site (S661, S667, S671, S683) Binding of a substrate and ATP molecule occur simultaneously. Following binding of each, ATP hydrolysis shifts the substrate into a position to be excreted from the cell. Release of the phosphate (from the original ATP molecule) occurs concurrently with substrate excretion. ADP is released, and a new molecule of ATP binds to the secondary ATP-binding site. Hydrolysis and release of ADP and a phosphate molecule resets the protein. It affects oral absorption, brain penetration, drug excretion, multidrug resistance tumor cells, and resistance to antibiotics. Pgp has broad substrate specificity and impacts PK profiles of many drug candidates.

10. Pgp was initially identified as a major cause of resistance by cancer cells to multiple drugs (e.g., paclitaxel, etoposide) having a variety of structures. It was also discovered that Pgp is present in many tissues of the body. Pgp is abundant in cell barriers that have a protective function blood-brain barrier, small and large intestine liver, kidney, adrenal gland, pregnant uterus. Pgp is expressed on the luminal surface of gastrointestinal epithelial cells, where it can reduce the total permeability of Pgp substrates. In the liver and kidney, Pgp enhances drug and metabolite clearance to the bile and urine, respectively. Pgp attenuates penetration of some compounds into the brain, uterus, testes and other tissues.

11. 9.3.1.1 Rules for Pgp Efflux Substrates “rule of 4” for a Pgp substrate “rule of 4” for a Pgp non-substrate Increasing numbers of hydrogen bond acceptors (N+O) appear to confer increasing likelihood of Pgp efflux. This may be because binding to Pgp occurs in the lipophilic membrane region. Hydrogen bonds afford energetic binding interactions. Another contributor to Pgp binding may be a structural motif involving two H-bond acceptors 4.6A apart or three H-bond acceptors 2.5 A apart.

12. 9.3.1.3 Structure Modification Strategies to Reduce Pgp Efflux ( 중요 ) -12- 1. Steric hindrance adjacent to H-bond acceptor Attach a bulky group / Me-N-Me 2. Decrease H-bond acceptor Add an adjacent electron withdrawing group Replace or remove the H-bonding group (e.g., amide) 3. Reduce liphophicity (Log P) 4. Add group that can disrupt PgP binding

13. Case Study of Pgp Efflux (Structure-Efflux Relationship) -13-  Decreasing Hydrogen bonding acceptor reduces PgP efflux

14. -14- (A) (B) Caco-2 cell

15. -15-  Increasing steric hindrance reduces PgP efflux  Adding a carboxylic acid reduces PgP effulx

16. 9.3.2 Breast Cancer Resistance Protein (BCRP, ABCG2) [Efflux] BCPR efflux transporter was identified from chemotherapeutically resistant breast tumor cells. 9.3.3 Multidrug Resistance Protein 2 (MRP2, ABCC2) [Efflux] - MRP2 is an efflux transporter that came to light because it can also contribute to cancer multidrug resistance. - It has also been termed cMOAT for multispecific organic anion transporter. - MRP2 transports glutathione, glucuronide, and sulfate conjugates of lipophilic compounds and some uncongugated compounds. 9.3.4 Efflux Transporters in the BBB - Efflux transporters at the BBB include : Pgp, MRPs, BCRP, OATs, OATPs, EAATs (glutamic acid/acidic amino acids), and TAUT (taurine). - These transporters export their substrates from the brain and BBB endothelial cells into the blood.

17. -17- PAMPA (LC/MS/MS) - PAMPA 평가가 완료된 sample 을 LLE extraction 후 LC/MS/MS 로 분석. - Acceptor part 와 Reference, Donor 를 각각 정량 분석한 후 정량 값을 입력하여 산출함. -logPe ≥ 6  Low 5≤-logPe <6  Medium -logPe ≤ 4  High Acceptor 의 값은 BQL 이나 계산함.

18. CaCo-2 efflux assay -18-